Basic Information
Fluticasone Furoate and Vilanterol Trifenatate Powder for Inhalation (Ⅱ)
糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ)
每泡含糠酸氟替卡松100μg与三苯乙酸维兰特罗25μg（按C₂₄H₃₃Cl₂NO₅计），递送剂量为糠酸氟替卡松92μg与三苯乙酸维兰特罗22μg（按C₂₄H₃₃Cl₂NO₅计）
吸入制剂
Regulatory Information
国药准字HJ20180044
Approved
化学药品
June 7, 2023
Company Information
glaxo operations(uk)ltd. (trading as glaxo wellcome operations)